Inhibitory effect of ZD6474 combined with adriamycin on MCF-7 human breast cancer cells in vitro / 南方医科大学学报
Journal of Southern Medical University
; (12): 523-525, 2010.
Article
en Zh
| WPRIM
| ID: wpr-355084
Biblioteca responsable:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the killing effect of ZD6474 combined with adriamycin (ADM) on MCF-7 human breast cancer cells.</p><p><b>METHODS</b>The inhibitory effects of ZD6474 and ADM alone and in combination on the proliferation of MCF-7 cells were assessed by MTT assay. The cell cycle and cell apoptosis were detected by flow cytometry.</p><p><b>RESULTS</b>ZD6474 and ADM both significantly inhibited the proliferation of MCF-7 cells, showing a synergistic effect of their reactions in combined use (P<0.05). ZD6474 or ADM alone caused cell cycle arrest at G0/G1 and S phases, respectively. Combined use of the two drugs resulted in significant reduction of the M-phase cell percentage and cell cycle arrest at G0/G1 and S phases. The coadministration of the drugs significantly increased the apoptosis rate of the cells as compared with ZD6474 or ADM treatment alone (P<0.05).</p><p><b>CONCLUSIONS</b>ZD6474 and ADM show a synergistic effect in inhibiting the proliferation and inducing apoptosis of MCF-7 cells.</p>
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Patología
/
Farmacología
/
Piperidinas
/
Quinazolinas
/
Neoplasias de la Mama
/
Doxorrubicina
/
Ciclo Celular
/
Apoptosis
/
Línea Celular Tumoral
/
Proliferación Celular
Límite:
Female
/
Humans
Idioma:
Zh
Revista:
Journal of Southern Medical University
Año:
2010
Tipo del documento:
Article